Triglycerides and Cardiovascular Disease

10.1016/S0002-9149(98)00031-9

10.1161/CIRCULATIONAHA.106.637793

10.1056/NEJM198006193022503

10.1001/jama.1984.03340330054025

10.1001/jama.1993.03500040071040

10.1001/jama.294.14.1773

10.1001/jama.288.14.1723

10.1161/01.cir.0000161369.71722.10

10.1161/CIRCULATIONAHA.109.192627

10.1001/jama.285.19.2486

10.1016/j.amjcard.2010.05.030

10.1093/oxfordjournals.aje.a113490

10.1056/NEJM199304293281702

10.1161/01.CIR.88.4.1421

10.2337/diacare.6.4.361

10.1007/BF00265546

10.1001/jama.2009.1619

10.2337/dc08-9017

10.1161/01.CIR.0000108926.04022.0C

10.1161/01.CIR.97.11.1029

10.1001/jama.298.3.299

10.1001/jama.298.3.309

10.1016/0021-9150(77)90157-5

10.1161/01.CIR.55.5.767

10.1136/hrt.39.11.1179

10.1016/0021-9681(78)90049-8

10.1161/01.ATV.1.4.273

10.1016/0021-9150(82)90122-8

10.1016/0021-9150(86)90051-1

10.1161/01.CIR.56.5.875

10.1093/oxfordjournals.aje.a112511

10.1016/0002-9343(82)90183-8

10.1161/01.CIR.71.5.881

10.1093/oxfordjournals.aje.a114906

10.1001/jama.1988.03410130125037

10.1097/00043798-199604000-00014

10.7326/0003-4819-147-6-200709180-00007

10.1111/j.0954-6820.1988.tb15891.x

10.1161/01.CIR.85.1.37

10.1161/hc5001.100624

10.1016/S0889-8529(05)70023-2

10.1097/MOL.0b013e3281527914

10.1161/01.RES.27.4.595

10.1016/S0021-9258(19)39557-2

10.1074/jbc.M411412200

10.1016/j.atherosclerosis.2009.12.027

10.1016/S0006-291X(72)80149-9

10.1194/jlr.M002618

10.1016/S0022-2275(20)34932-4

10.1097/MOL.0b013e3282feec2d

10.1016/S1388-1981(99)00083-9

10.1021/bi7000533

10.2337/diacare.14.9.839

10.1074/jbc.R100068200

10.1074/jbc.M008725200

10.1194/jlr.M100431-JLR200

10.1016/0002-9343(93)90144-E

10.1016/S0002-9149(02)02749-2

10.7326/0003-4819-150-7-200904070-00007

10.1093/clinchem/18.6.499

10.1016/S0002-9149(98)00034-4

10.2337/diabetes.51.6.1949

10.1042/BST0350454

10.1016/j.atherosclerosis.2008.05.024

10.1016/j.atherosclerosis.2006.09.015

10.1161/01.cir.0000117403.64398.53

10.1161/01.res.0000258023.76515.a3

10.1161/01.cir.0000148820.55611.6b

10.1194/jlr.M700505-JLR200

10.1016/j.atherosclerosis.2003.12.001

10.1016/j.atherosclerosis.2008.07.047

10.1186/1476-511X-8-14

Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest. 2008; 118: 2640–2650.

10.1042/CS20070308

10.1126/science.1161524

10.1161/CIRCRESAHA.108.189860

10.1161/circulationaha.106.622514

10.1161/CIRCULATIONAHA.105.591743

10.1161/CIRCULATIONAHA.108.784785

10.1161/circresaha.108.178426

10.1172/JCI6117

10.1016/S0022-2275(20)37569-6

10.1161/01.ATV.20.9.e53

10.1194/jlr.M600159-JLR200

10.1161/01.atv.0000259361.91267.8c

10.1194/jlr.R800032-JLR200

10.1172/JCI107332

10.1016/0026-0495(76)90089-5

10.1161/01.CIR.85.6.2025

10.1161/01.cir.0000081777.17879.85

Brunzell JD. Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndrome. In: , Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Base of Inherited Disease. New York, NY: McGraw- Hill; 1995: 1913–1932.

10.1161/01.ATV.0000153087.36428.dd

10.1086/324647

10.1016/j.amjmed.2007.10.004

Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med. 1992; 37: 249–273.

10.1016/j.ecl.2008.11.005

10.1172/JCI107334

10.1016/S0140-6736(10)60545-4

10.1056/NEJM199609193351203

10.1161/01.ATV.19.11.2708

10.1161/01.CIR.101.24.2777

10.1194/jlr.M002717

10.1161/atvbaha.109.186577

10.1056/NEJM199106203242502

10.1097/MOL.0b013e3283319a1d

10.3748/wjg.v10.i24.3691

Miller M. Disorders of hypertriglyceridemia. In: , Kwiterovich PO, ed. The Johns Hopkins Textbook of Dyslipidemia. Baltimore, MD: Lippincott Williams & Wilkins; 2009: 74–88.

10.1016/S0025-7125(16)30179-1

Herrera E, Amusquivar E, López-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res. 2006; 65(suppl 3): 59–64.

10.1136/jcp.47.8.728

10.1016/S0301-2115(97)00154-1

10.1016/S0950-351X(05)80078-3

10.1002/dmr.5610060103

10.1053/gast.2000.8528

10.1111/j.1600-0447.2008.01334.x

10.1016/S0002-9343(88)80111-6

10.1016/0002-9343(87)90692-9

10.1111/j.1744-9987.2008.00647.x

Parker WA. Estrogen-induced pancreatitis. Clin Pharm. 1983; 2: 75–79.

10.1086/517194

10.2337/diacare.28.7.1555

10.7326/0003-4819-107-1-63

10.1097/TP.0b013e3181caa5e4

10.1210/jcem.83.5.4753

10.1097/00005344-199312050-00016

10.1001/archinte.159.9.981

10.1016/j.alcohol.2009.07.003

10.1016/j.atherosclerosis.2009.07.039

10.1016/j.autrev.2007.11.016

10.1530/eje.0.1410502

10.1111/j.1525-139X.2009.00661.x

10.1111/j.1463-1326.2008.00927.x

10.1016/S0002-9343(97)80024-1

Banks PA, Conwell DL, Toskes PP. The management of acute and chronic pancreatitis. Gastroenterol Hepatol (N Y). 2010; 6(suppl 3): 1–16.

Stone NJ. Clinical evaluation for genetic and secondary causes of dyslipidemia. In: , Ballantyne C, ed. Clinical Lipidology, A Companion to Braunwald's Heart Disease. Philadelphia, PA: Saunders; 2009: 144–157.

10.1210/jc.2005-0205

10.1161/01.atv.0000142358.46276.a7

10.1161/01.cir.0000130646.93255.86

10.1194/jlr.M600312-JLR200

10.1161/01.atv.0000099881.83261.d4

10.1038/ng1320

10.1161/atvbaha.107.151530

10.1093/eurheartj/ehp051

10.1042/CS20070220

10.1042/CS20060234

10.1146/annurev.genet.34.1.233

10.1016/S0022-2275(20)32417-2

10.1042/CS20070265

10.1016/j.clnu.2009.01.018

10.1038/ng.291

10.1038/ng.628

10.1056/NEJMra0905980

10.1001/archinternmed.2008.599

Centers for Disease Control and Prevention. Prevalence of abnormal lipid levels among youths: United States, 1999–2006 [published correction appears in MMWR Morb Mortal Wkly Rep. 2010;59:78]. MMWR Morb Mortal Wkly Rep. 2010; 59: 29–33.

10.1161/CIRCULATIONAHA.106.675355

10.2337/diacare.26.5.1413

10.1161/atvbaha.107.159228

10.1161/circulationaha.107.743062

10.2337/dc08-2280

10.1097/MOL.0b013e32832d4a33

10.1097/01.mol.0000217898.52197.18

10.1056/NEJMra025261

Garg A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab. 2000; 85: 1776–1782.

10.1097/00041433-200402000-00011

10.1001/jama.2010.1004

10.1001/jama.1990.03440210043030

10.2337/diacare.27.9.2234

10.2337/diacare.29.03.06.dc05-1254

10.1093/oxfordjournals.bmb.a072317

10.1056/NEJMcp070061

10.1016/S0002-9149(98)00848-0

10.1016/j.metabol.2006.10.028

10.1007/s00125-009-1611-5

10.1053/j.gastro.2009.05.051

10.1016/j.atherosclerosissup.2008.05.011

10.2337/diab.31.3.217

10.1161/01.atv.0000090521.25968.4d

10.1172/JCI200523219

10.1177/204748739900600512

10.1001/jama.1995.03520260035025

10.1172/JCI116384

10.1242/dmm.001180

10.1161/CIRCULATIONAHA.105.169404

10.1161/CIRCULATIONAHA.109.192644

10.2337/diacare.28.10.2508

10.1161/CIRCHEARTFAILURE.108.785485

10.1253/circj.70.1531

10.1159/000076695

10.1536/ihj.50.571

10.1161/01.CIR.102.2.179

10.1007/s00467-007-0467-5

10.1159/000144024

10.1053/ajkd.1998.v32.pm9820472

10.1111/j.1600-6135.2004.0355.x

10.1056/NEJM196807252790403

10.1016/S0272-6386(12)70182-8

10.1038/ki.1996.192

10.1001/jama.291.4.451

10.1681/ASN.2006060674

10.1046/j.1523-1755.2002.00324.x

10.1016/j.jacc.2008.03.025

10.1056/NEJMoa043545

10.1056/NEJMoa0810177

10.1016/j.amjcard.2007.11.046

10.1161/01.ATV.19.3.753

10.2337/db08-1794

10.1016/j.atherosclerosis.2008.03.014

10.1161/01.CIR.81.2.470

10.2337/diacare.26.1.16

10.1016/j.amjcard.2006.06.032

10.1001/jama.294.3.326

10.1161/01.cir.0000038496.57570.06

10.1161/atvbaha.108.181735

10.1001/archinte.161.11.1413

10.1016/j.atherosclerosis.2008.12.043

10.1212/01.wnl.0000294323.48661.a9

10.1111/j.1365-2796.2008.02016.x

10.1161/CIRCULATIONAHA.108.777334

10.1542/peds.110.3.e29

10.1016/S0002-9149(00)00918-8

10.1542/peds.2005-1856

National Cholesterol Education Program (U.S.). Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report. Washington, DC: National Institutes of Health, National Heart, Lung, and Blood Institute; 2002. NIH publication No. 02-5215.

10.1016/j.jacc.2008.10.024

10.1016/j.amjcard.2005.04.019

10.1016/j.ahj.2008.03.005

10.1111/j.1751-7141.2008.00014.x

10.1016/0002-9149(93)90008-Z

10.1161/01.CIR.73.5.978

10.1016/S0140-6736(03)12663-3

10.1111/j.1365-2796.2006.01616.x

10.1016/j.jacc.2008.04.052

10.1038/ncpendmet0982

10.1016/0002-9149(92)90550-I

10.1016/j.amjcard.2005.03.085

10.1001/archinte.165.12.1395

10.1016/j.amjcard.2004.03.069

10.1111/j.1399-5448.2006.00199.x

10.1161/01.CIR.96.8.2520

10.2337/diacare.28.1.101

10.1016/j.ahj.2008.11.014

10.1001/archinte.161.3.361

10.2337/diacare.27.4.936

10.1016/j.annepidem.2005.01.005

National Cholesterol Education Program (U.S.). Working Group on Lipoprotein Measurement. Recommendations on Lipoprotein Measurement. Bethesda, Md.: National Institutes of Health, National Heart, Lung, and Blood Institute; 1995. NIH publication No. 95-3044.

10.1093/clinchem/24.5.824

10.1093/clinchem/38.4.569

10.1016/0091-7435(86)90032-0

10.1093/clinchem/23.1.60

10.1016/S0022-2275(20)41517-2

10.1161/01.CIR.60.3.473

10.2741/Yu

10.1172/JCI103491

10.1073/pnas.80.5.1449

10.1161/01.ATV.12.11.1336

10.1161/01.ATV.6.3.297

10.1172/JCI113243

10.1016/S0022-2275(20)38424-8

10.1093/ajcn/47.5.825

10.1016/S0022-2275(20)38520-5

10.1210/jcem-71-4-1041

10.1161/01.ATV.11.3.653

De Bruin TW, Brouwer CB, Gimpel JA, Erkelens DW. Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am J Physiol. 1991; 260 (part 1): E492–E498.

10.1161/01.ATV.13.10.1533

10.1073/pnas.90.5.2069

10.1172/JCI116293

10.1161/01.ATV.13.3.385

10.7326/0003-4819-121-8-199410150-00004

10.1093/ajcn/60.4.586

10.1161/01.ATV.15.12.2111

10.1093/ajcn/61.2.325

10.1161/01.ATV.15.2.199

10.1161/01.ATV.15.11.1829

Roche HM, Gibney MJ. Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation. Eur J Clin Nutr. 1996; 50: 617–624.

10.1016/S0002-9149(96)00760-6

10.1093/ajcn/65.1.36

10.1001/jama.1997.03550200058032

10.1093/ajcn/67.1.31

10.1093/jn/128.3.582

10.1016/S0021-9150(98)00184-1

10.1093/jn/129.12.2184

Mekki N, Christofilis MA, Charbonnier M, Atlan-Gepner C, Defoort C, Juhel C, Borel P, Portugal H, Pauli AM, Vialettes B, Lairon D. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J Clin Endocrinol Metab. 1999; 84: 184–191.

10.1161/01.ATV.19.10.2448

10.1053/meta.2000.8612

Couillard C, Bergeron N, Bergeron J, Pascot A, Mauriège P, Tremblay A, Prud'homme D, Bouchard C, Després JP. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations. J Clin Endocrinol Metab. 2000; 85: 4575–4582.

10.1016/S0735-1097(00)00896-2

Ooi TC, Cousins M, Ooi DS, Steiner G, Uffelman KD, Nakajima K, Simo IE. Postprandial remnant-like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab. 2001; 86: 3134–3142.

10.1093/ajcn/80.5.1145

10.1016/S0022-2275(20)40633-9

10.1080/07315724.2004.10719359

10.1161/01.ATV.20.8.1998

10.1056/NEJM199806043382302

10.1001/jama.1990.03450230070031

10.1161/circulationaha.106.179568

10.1542/peds.2008-1349

10.1542/peds.103.6.1175

10.1161/circulationaha.109.192215

10.1007/BF00402173

10.2337/diab.46.8.1341

10.1016/j.jadohealth.2008.03.002

10.1542/peds.2004-2001

10.1001/archpediatrics.2009.21

10.1016/0002-8703(86)90296-6

10.1001/archinte.1993.00410190045006

10.1111/j.1445-5994.2005.00940.x

10.1161/cir.0b013e31820faaf8

10.1097/01.mol.0000174154.61307.16

10.1161/circulationaha.107.704569

10.2337/diacare.27.10.2444

10.2337/diacare.28.2.385

10.1001/archinte.163.4.427

10.1056/NEJM198410113111505

10.1016/0002-8703(87)90552-7

10.1152/ajpendo.00246.2006

10.1210/jc.2003-030506

10.1053/meta.2000.8603

10.1161/01.ATV.15.7.821

10.1210/jc.2007-1756

10.1016/S1047-2797(97)00119-1

10.1056/NEJM199011153232003

10.2337/diacare.25.6.1027

Connelly PW, Stachenko S, MacLean DR, Petrasovits A, Little JA; Canadian Heart Health Surveys Research Group. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Can J Cardiol. 1999; 15: 419–427.

10.1016/S0010-7824(01)00224-4

10.1136/jcp.47.12.1105

10.1016/0026-0495(94)90186-4

10.1177/107155769800500504

10.1210/jcem.85.12.7027

10.2337/dc09-1196

10.2337/diab.41.12.1651

10.3109/00016341003605677

10.1253/circj.70.768

10.1016/1047-2797(94)90003-5

10.3109/00016348509157146

10.1093/ije/19.1.42

10.1210/jcem-67-1-30

10.1093/oxfordjournals.aje.a010246

10.1093/aje/kwp043

10.1001/jama.1995.03520270033028

10.1016/S0015-0282(01)01699-5

10.1001/archinte.158.16.1803

10.1016/S0197-2456(98)00010-5

10.1016/S0197-2456(97)00078-0

10.1093/fampra/17.6.497

10.1016/0002-9378(92)91370-P

10.1001/archinte.164.8.871

10.1001/jama.287.7.847

10.1016/j.atherosclerosissup.2006.01.003

10.1016/j.atherosclerosis.2008.09.023

10.1089/met.2009.0024

10.1093/oxfordjournals.aje.a117632

10.1161/01.CIR.99.18.2389

10.1016/j.atherosclerosis.2006.12.018

10.1016/j.metabol.2007.02.008

10.1046/j.1463-1326.2001.00113.x

Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995; 90: 2134–2139.

10.1097/MPA.0b013e31816074a1

10.1007/BF02795245

10.1097/00004836-200204000-00020

10.1016/S0025-7125(16)31430-4

10.1016/S0002-9394(02)02076-7

10.1161/01.atv.0000173310.85845.7b

10.1038/oby.2009.89

Gebre-Yohannes A, Rahlenbeck SI. Coronary heart disease risk factors among blood donors in northwest Ethiopia. East Afr Med J. 1998; 75: 495–500.

Vorster HH, Kruger A, Venter CS, Margetts BM, Macintyre UE. Cardiovascular disease risk factors and socio-economic position of Africans in transition: the THUSA study. Cardiovasc J Afr. 2007; 18: 282–289.

10.1079/BJN19780022

10.1038/sj.ejcn.1602251

10.1016/S0140-6736(96)01391-8

10.1093/oxfordjournals.aje.a010127

10.1016/S1047-2797(03)00069-3

10.1016/S0167-5273(96)02916-6

10.2486/indhealth.40.28

10.1093/oxfordjournals.aje.a008891

10.1186/1475-2840-8-34

10.1136/jech.52.11.707

10.1002/clc.4960221402

Castelli WP. Cholesterol and lipids in the risk of coronary artery disease: the Framingham Heart Study. Can J Cardiol. 1988;(suppl A): 5A–10A.

10.1016/0002-9149(94)90722-6

10.1016/S0735-1097(98)00083-7

10.1016/S0021-9150(99)00190-2

10.1016/j.jacc.2007.10.038

10.1016/j.metabol.2009.04.009

10.1016/j.ijcard.2005.06.056

10.1056/NEJMsa053935

10.1210/jc.2003-030388

10.1136/bmj.c1826

10.1038/sj.ejcn.1602976

Pasanisi F, Contaldo F, de Simone G, Mancini M. Benefits of sustained moderate weight loss in obesity. Nutr Metab Cardiovasc Dis. 2001; 11: 401–406.

10.1093/eurheartj/sui082

10.1111/j.1467-789X.2004.00127.x

10.1038/oby.2001.138

10.1093/ajcn/56.2.320

10.17226/10490

10.1016/j.jacl.2008.12.008

10.1093/ajcn/77.5.1146

10.1093/ajcn/86.5.1611

10.1056/NEJM199704173361601

10.1093/ajcn/74.1.80

10.1001/jama.294.19.2455

10.1001/jama.295.6.655

10.3945/ajcn.2009.27908

10.3945/jn.108.103424

10.1001/jama.292.12.1440

10.1093/ajcn/82.5.964

10.1001/archinte.168.22.2449

10.1161/01.CIR.99.6.779

10.1097/00005082-200601000-00003

10.2337/diacare.26.7.1979

10.1080/07315724.2004.10719338

10.1093/jn/116.suppl_11.S1

10.1001/jama.2010.449

Dietary Guidelines for Americans. 2005; 6th ed. US Department of Health and Human Services Web site. http://www.healthierus.gov/dietaryguidelines. Accessed September 13 2010.

10.1079/PHN2003592

10.1097/00041433-200502000-00012

10.1007/s11883-008-0077-0

10.1001/archinternmed.2009.38

10.1093/ajcn/73.3.560

10.1016/j.metabol.2007.11.002

10.1038/sj.ejcn.1601992

10.1016/j.nut.2009.08.014

10.1038/sj.ejcn.1601086

10.1093/eurheartj/ehl389

10.1093/ajcn/86.4.988

10.1002/14651858.CD004467.pub2

10.1093/ajcn/81.5.976

10.1093/ajcn/86.3.707

10.1093/ajcn/87.1.114

10.3945/ajcn.2008.25825D

Putnam JJ, Allshouse JE. Food Consumption, Prices, and Expenditures, 1970–97. Washington, DC: Food and Rural Economics Division, Economic Research Service, US Department of Agriculture; 1999. Statistical Bulletin No. 965.

10.1111/j.1749-6632.2009.05266.x

Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr. 2008; 88: 1419–1437.

10.1021/jf051433u

10.1172/JCI0215593

10.1111/j.1749-6632.2009.04956.x

10.1016/j.cmet.2006.06.008

10.1056/NEJMoa0804748

10.1056/NEJMp030053

10.1001/archinte.166.3.285

10.1056/NEJMoa012512

10.7326/0003-4819-142-8-200504190-00009

Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, Berkowitz RI, Kelley DE, Tomchee C, Hill JO, Kumanyika S; Look AHEAD Research Group. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it [published correction appears in Obesity (Silver Spring). 2007;15:1339]. Obesity (Silver Spring). 2006; 14: 737–752.

10.1056/NEJMoa0708681

10.1001/jama.293.1.43

10.1001/jama.297.9.969

10.1161/01.CIR.103.3.472

10.1016/0021-9150(94)05517-M

10.1093/ije/29.1.57

10.1038/sj.ejcn.1601854

10.1136/bmj.304.6819.80

10.1097/01.hjr.0000065928.57001.4d

10.1016/j.amjcard.2008.09.089

10.1136/bmj.319.7224.1523

10.1093/ajcn/70.5.791

10.1016/S0022-2275(20)39917-X

Erkelens DW, Brunzell JD. Effect of controlled alcohol feeding on triglycerides in patients with outpatient “alcohol hypertriglyceridemia.” J Hum Nutr. 1980; 34: 370–375.

10.1161/01.cir.0000038493.65177.94

10.1093/ajcn/65.5.1645S

Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B, Lawrence A, DeVine D, Lau J. Effects of Omega-3 Fatty Acids on Cardiovascular Risk Factors and Intermediate Markers of Cardiovascular Disease. Evidence Report/Technology Assessment No. 93 (prepared by Tufts-New England Medical Center Evidence-Based Practice Center under contract No. 290-02-0022). AHRQ publication No. 04-E010-2. Rockville, MD: Agency for Healthcare Research and Quality; 2004.

10.1097/00004872-199409000-00008

10.1093/ajcn/87.6.1981S

10.1517/14656566.9.7.1237

10.1016/j.atherosclerosis.2007.11.008

10.1111/j.1753-4887.2004.tb00058.x

10.1093/ajcn/66.3.649

10.1007/s11745-998-0188-8

10.1093/ajcn/86.2.324

10.1161/01.atv.0000038493.65177.94

10.1016/j.jnutbio.2009.12.004

10.1016/S0939-4753(04)80037-1

10.1097/FJC.0b013e3181af04e5

10.3945/jn.108.094268

10.1016/j.plefa.2009.01.004

10.2337/diab.46.6.983

10.1146/annurev.nutr.22.010402.102912

10.1055/s-2001-15114

10.1249/00003677-199600240-00009

10.1161/hq0701.092137

10.1001/archinte.1995.00430040091011

10.1056/NEJMoa020194

10.1001/archinte.165.20.2362

10.1152/ajpendo.00102.2007

10.1016/S0955-2863(02)00275-9

10.1161/hq0901.095553

Jones PH. Fibrates. In: Ballantyne C ed. Clinical Lipidology A Companion to Braunwald's Heart Disease. Philadelphia PA: Saunders; 2009: 315–325.

Harris WS, Jacobson TA. Omega-3 Fatty Acids. In: , Ballantyne C, ed. Clinical Lipidology, A Companion to Braunwald's Heart Disease. Philadelphia, PA: Saunders; 2009: 326–338.

McKenney JM, Ganz P, Wiggins BS, Saseen JS. Statins. In: , Ballantyne C, ed. Clinical Lipidology, A Companion to Braunwald's Heart Disease. Philadelphia, PA: Saunders; 2009: 253–280.

Norata GD, Catapano AL. In: , Ballantyne C, ed. Clinical Lipidology, A Companion to Braunwald's Heart Disease. Philadelphia, PA: Saunders; 2009: 288–297.

10.1097/00008483-200211000-00002

10.1016/j.amjcard.2003.09.028

10.2337/diacare.20.4.614

10.1161/01.CIR.102.16.1886

10.1161/01.cir.0000080897.52664.94

10.1016/S0140-6736(06)69292-1

10.1016/S0735-1097(98)00522-1

10.1056/NEJM199811053391902

10.1016/S0140-6736(02)09327-3

10.1056/NEJM199511163332001

10.1016/S0140-6736(03)12948-0

10.1161/01.CIR.102.1.21

10.1001/archinte.165.10.1154

10.1016/S0140-6736(05)67667-2

10.2337/dc08-1543

10.1056/NEJM199908053410604

10.1001/jama.285.12.1585

10.1056/NEJMoa1001282

10.1161/01.CIR.101.5.477

10.1161/hc1002.105136

10.1016/j.amjcard.2009.04.008

10.1016/S0140-6736(07)60527-3

10.1016/j.atherosclerosis.2008.06.003

Brown B, Canner PL, McGovern ME, Guyton JR, Carlson LA. Nicotinic acid. In: , Ballantyne C, ed. Clinical Lipidology, A Companion to Braunwald's Heart Disease. Philadelphia, PA: Saunders; 2009: 298–314.

10.1056/NEJMoa0907569

Brown G Boden W. Niacin Plus Statin to Prevent Vascular Events. http://clinicaltrials.gov/ct/show/NCT00120289. Accessed July 27 2010.

A Randomized Trial of the Long-Term Clinical Effects of Raising HDL Cholesterol With Extended Release Niacin/Laropiprant. http://clinicaltrials.gov/ct2/show/NCT00461630. Accessed July 27 2010.

10.1016/j.ahj.2008.07.023

10.1001/jama.288.14.1728

10.1038/sj.ijo.0800541

10.1542/peds.101.S2.518

Boehmer TK, Brownson RC, Haire-Joshu D, Dreisinger ML. Patterns of childhood obesity prevention legislation in the United States. Prev Chronic Dis. 2007; 4: A56.

10.1186/1479-5868-3-1

10.1016/j.jada.2008.10.065

Labarthe DR. Heart-healthy and stroke-free, 2008. Prev Chronic Dis. 2008; 5: A32.

10.1161/circulationaha.105.169179

Strauss R. Childhood obesity. Curr Probl Pediatr. 1999; 29: 1–29.

10.1016/j.jada.2008.12.021

10.1016/j.jneb.2008.05.007

10.1057/jphp.2008.64

10.1177/0193945909336356

10.3148/70.2.2009.101

10.1016/j.jada.2009.04.017

10.1016/0140-6736(92)90863-X

10.1161/circulationaha.110.971812

10.1161/CIRCULATIONAHA.109.915165

10.1371/journal.pmed.1000252

10.1159/000283561